Methotrexate (MTX) is an effective drug used to treat various diseases, especially rheumatological diseases. However, myelosuppression is a severe side effect, the frequency of which increases in patients with renal insufficiency. Here, we presented a chronic hemodialysis patient who developed pancytopenia and mucositis after using low-dose MTX to treat psoriasis.
Although it has been reported rarely in the literature in patients who develop acute kidney injury after COVID-19 disease, ANCA-related vasculitis should also be kept in mind. Thus, it is possible to reduce mortality and morbidity. We presented a middle-aged male patient who was diagnosed with post-COVID ANCA-associated vasculitis.
Renal vein thrombosis (RVT) is the presence of thrombi in major renal veins or their branches and is a rare clinical entity. RVT is one of the common thrombotic complications of nephrotic syndrome or renal cell carcinoma. Hormonal contraception can also rarely cause this complication. Herein, we presented a case of renal vein thrombosis accompanied by subnephrotic proteinuria after oral contraception.
Psoriasis is a chronic, recurrent, inflammatory and common skin disease of unknown aetiology. Amyloidosis is defined as a heterogeneous group of diseases in which generally soluble plasma proteins accumulate in the extracellular space as insoluble abnormal fibrils. Type AA amyloidosis is a late and severe complication of chronic inflammatory disorders and some chronic infections. Although psoriasis is a common inflammatory skin disease, the development of amyloidosis is rare. Herein, we presented a case of psoriasis who developed AA-type amyloidosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.